Meylan PR - Search Results

1

Oral valganciclovir for cytomegalovirus colitis after liver transplantation.

Manuel O, Meylan PR, Rotman S, Fontana M, Moradpour D, Pascual M. Manuel O, et al. Among authors: meylan pr. Transplantation. 2007 Jan 27;83(2):239-40. doi: 10.1097/01.tp.0000242138.33261.ef. Transplantation. 2007. PMID: 17264825 No abstract available.

2

What is the impact of late-onset cytomegalovirus disease after valganciclovir prophylaxis in kidney transplantation?

Lamoth F, Manuel O, Venetz JP, Faouzi M, Meylan P, Pascual M. Lamoth F, et al. Transplantation. 2008 Nov 15;86(9):1323-4. doi: 10.1097/TP.0b013e3181890788. Transplantation. 2008. PMID: 19005418 No abstract available.

3

Ganciclovir exposure under a 450 mg daily dosage of valganciclovir for cytomegalovirus prevention in kidney transplantation: a prospective study.

Manuel O, Pascual M, Perrottet N, Lamoth F, Venetz JP, Decosterd LA, Buclin T, Meylan PR. Manuel O, et al. Among authors: meylan pr. Clin Transplant. 2010 Nov-Dec;24(6):794-800. doi: 10.1111/j.1399-0012.2009.01205.x. Clin Transplant. 2010. PMID: 20105200

4

Impact of a preemptive strategy after 3 months of valganciclovir cytomegalovirus prophylaxis in kidney transplant recipients.

Boillat Blanco N, Pascual M, Venetz JP, Nseir G, Meylan PR, Manuel O. Boillat Blanco N, et al. Among authors: meylan pr. Transplantation. 2011 Jan 27;91(2):251-5. doi: 10.1097/TP.0b013e318200b9f0. Transplantation. 2011. PMID: 21099744

5

Impact of anti-T-cell therapy in the immunogenicity of seasonal influenza vaccine in kidney transplant recipients.

Orcurto A, Pascual M, Hoschler K, Aubert V, Meylan P, Manuel O. Orcurto A, et al. Transplantation. 2012 Sep 27;94(6):630-6. doi: 10.1097/TP.0b013e31825f7f82. Transplantation. 2012. PMID: 22895612

6

Fatal Outcome of Multiple Clinical Presentations of Human Herpesvirus 8-related Disease After Solid Organ Transplantation.

Vijgen S, Wyss C, Meylan P, Bisig B, Letovanec I, Manuel O, Pascual M, de Leval L. Vijgen S, et al. Transplantation. 2016 Jan;100(1):134-40. doi: 10.1097/TP.0000000000000801. Transplantation. 2016. PMID: 26120765

7

Cytomegalovirus infection and new-onset post-transplant diabetes mellitus.

Leung Ki EL, Venetz JP, Meylan P, Lamoth F, Ruiz J, Pascual M. Leung Ki EL, et al. Clin Transplant. 2008 Mar-Apr;22(2):245-9. doi: 10.1111/j.1399-0012.2007.00758.x. Clin Transplant. 2008. PMID: 18339147

8

Association between mannose-binding lectin deficiency and cytomegalovirus infection after kidney transplantation.

Manuel O, Pascual M, Trendelenburg M, Meylan PR. Manuel O, et al. Among authors: meylan pr. Transplantation. 2007 Feb 15;83(3):359-62. doi: 10.1097/01.tp.0000251721.90688.c2. Transplantation. 2007. PMID: 17297414

9

Efficacy and safety of universal valganciclovir prophylaxis combined with a tacrolimus/mycophenolate-based regimen in kidney transplantation.

Manuel O, Venetz JP, Fellay J, Wasserfallen JB, Sturzenegger N, Fontana M, Matter M, Meylan PR, Pascual M. Manuel O, et al. Among authors: meylan pr. Swiss Med Wkly. 2007 Dec 1;137(47-48):669-76. doi: 10.4414/smw.2007.11961. Swiss Med Wkly. 2007. PMID: 18058275 Free article.

10

Treatment of cytomegalovirus infection or disease in solid organ transplant recipients with valganciclovir.

Fellay J, Venetz JP, Pascual M, Aubert JD, Seudoux C, Meylan PR. Fellay J, et al. Among authors: meylan pr. Am J Transplant. 2005 Jul;5(7):1781-2; author reply 1783. doi: 10.1111/j.1600-6143.2005.00936.x. Am J Transplant. 2005. PMID: 15943640 Free article. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

211 results

Search Page

Filters